Delivery Order SPE2DB22D1106-SPE2DB24FDVG0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp. is a delivery order worth $21,005.14 for the supply of 4558531687 - Lidocaine 5% Patch 30s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $96,657.22 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order contract valued at $3,739.23 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA) and has a period of performance through May 2, 2024. The contract is not designated as a set-aside and appears to be an open competition award. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
- This federal contract award to Amerisourcebergen Drug Corporation, the parent company of Amerisourcebergen Drug Corp, is a Delivery Order worth $2,482.56 for the supply of Lidocaine 5% patch 30s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $2,818.53 and a period of performance through November 14, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $10,440.25 for the supply of Lidocaine 5% Patch 30s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has an ultimate completion date of September 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $5,172.00 for the supply of 4564961123 - Lidocaine 5% Patch 30s. The contract, issued by the Defense Logistics Agency (DLA) which is part of the U.S. Department of Defense, does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This federal contract award, valued at $1,469.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $9,995.66, is for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 5% Patch 30S. The $1,315.20 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, as a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDVG0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $10,429.35 for the supply of Lidocaine 5% Patch 30S medical products. The contract is issued by the Defense Logistics Agency (DLA), which is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 1/16/24 |